Literature DB >> 352998

Levotryptophan treatment in migraine.

P Kangasniemi, B Falck, V A Långvik, M T Hyyppä.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 352998     DOI： 10.1111/j.1526-4610.1978.hed1803161.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  5 in total

1.  Visual and auditory evoked responses in patients with Parkinson's disease.

Authors:  M J Gawel; P Das; S Vincent; F C Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-03       Impact factor: 10.154

2.  5-OH-Tryptophane in migraine: clinical and neurophysiological considerations.

Authors:  A Boiardi; P Crenna; B Merati; S Negri; E Tansini; G Bussone
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

Review 3.  Genetic and biochemical changes of the serotonergic system in migraine pathobiology.

Authors:  Claudia Francesca Gasparini; Robert Anthony Smith; Lyn Robyn Griffiths
Journal:  J Headache Pain       Date:  2017-02-13       Impact factor: 7.277

4.  Association of plasma tryptophan concentration with periaqueductal gray matter functional connectivity in migraine patients.

Authors:  Kinga Gecse; Dóra Dobos; Csaba Sándor Aranyi; Attila Galambos; Daniel Baksa; Natália Kocsel; Edina Szabó; Dorottya Pap; Dávid Virág; Krisztina Ludányi; Gyöngyi Kökönyei; Miklós Emri; Gyorgy Bagdy; Gabriella Juhasz
Journal:  Sci Rep       Date:  2022-01-14       Impact factor: 4.379

5.  Citalopram Neuroendocrine Challenge Shows Altered Tryptophan and Kynurenine Metabolism in Migraine.

Authors:  Kinga Gecse; Andrea Edit Édes; Tamás Nagy; Adrienn Katalin Demeter; Dávid Virág; Márton Király; Borbála Dalmadi Kiss; Krisztina Ludányi; Zsuzsanna Környei; Adam Denes; Gyorgy Bagdy; Gabriella Juhasz
Journal:  Cells       Date:  2022-07-21       Impact factor: 7.666
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.